Letter: assessment of histological disease activity in Crohn's disease clinical trials-a step in the right direction, but further optimisation needed

Aliment Pharmacol Ther. 2021 Aug;54(4):541-542. doi: 10.1111/apt.16450.

Authors

Andrew H Tsoi¹, Anand Murugasu², Mayur Garg^{1

3}

Affiliations

¹ Department of Gastroenterology, Northern Hospital, Epping, VIC, Australia.
² Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville, VIC, Australia.
³ Department of Medicine, University of Melbourne, Parkville, VIC, Australia.

PMID: 34331790
DOI: 10.1111/apt.16450

No abstract available

Publication types

Letter
Comment

MeSH terms

Crohn Disease* / diagnosis
Crohn Disease* / drug therapy
Humans
Remission Induction